(University of Pennsylvania School of Medicine) Sticker shock may be leading many insured Americans with cancer to forego treatment with a wide range of oral cancer drugs, suggests a study published online this week in the Journal of Clinical Oncology. The findings point to high out-of-pocket costs as a barrier to potentially life-saving or life-prolonging treatments. As breakthroughs in cancer care continue, the study raises questions about whether patients will able to take advantage of new treatment options.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2DjTDAr
No comments:
Post a Comment